E-LIB Suche - Ergebnisse für: Lamanna, Jennifer D.

1

Adaptation of an obesity intervention program for pediatric..:

Stern, Marilyn ; Lamanna, Jennifer ; Russell, Claire...
Clinical Practice in Pediatric Psychology. 1 (2013) 3 - p. 264-275 , 2013

Link: https://doi.org/10.1037/..

2

Interprofessional Education: Preparing Psychologists for Su..:

Cubic, Barbara ; Mance, Janette ; Turgesen, Jeri N..
Journal of Clinical Psychology in Medical Settings. 19 (2012) 1 - p. 84-92 , 2012

Link: https://doi.org/10.1007/..

3

Representations of celebrities' weight and shape during pre..:

Gow, Rachel W. ; Lydecker, Janet A. ; Lamanna, Jennifer D..
Body Image. 9 (2012) 1 - p. 172-175 , 2012

Link: https://doi.org/10.1016/..

4

Fixed-Duration Pirtobrutinib plus Venetoclax with or withou..:

Roeker, Lindsey Elizabeth ; Woyach, Jennifer A. ; Cheah, Chan Yoon Y...
Blood Journal. , 2024

Link: https://doi.org/10.1182/..

5

Similar efficacy of ibrutinib arms across ALPINE and ELEVAT..:

Shadman, Mazyar ; Tedeschi, Alessandra ; Mohseninejad, Leyla...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

6

Characterization of zanubrutinib safety and tolerability pr..:

Brown, Jennifer R. ; Ghia, Paolo ; Jurczak, Wojciech...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

7

Pirtobrutinib, a highly selective, non-covalent (reversible..:

Wierda, William G ; Shah, Nirav N ; Cheah, Chan Y...
The Lancet Haematology. , 2024

Link: https://doi.org/10.1016/..

8

Plain language summary of zanubrutinib or ibrutinib in chro..:

Brown, Jennifer R ; Eichhorst, Barbara ; Hillmen, Peter...
Future Oncology. 20 (2024) 12 - p. 717-726 , 2024

Link: https://doi.org/10.2217/..

9

Health-related quality of life outcomes associated with zan..:

Tam, Constantine S. ; Lamanna, Nicole ; O'Brien, Susan M....
Current Medical Research and Opinion. 39 (2023) 11 - p. 1497-1503 , 2023

Link: https://doi.org/10.1080/..

10

Treatment Discontinuation Patterns for Patients With Chroni..:

Shadman, Mazyar ; Manzoor, Beenish S. ; Sail, Kavita...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 7 - p. 515-526 , 2023

Link: https://doi.org/10.1016/..

11

P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CH..:

Lansigan, Frederick ; A. Eyre, Toby ; Ghosh, Nilanjan...
HemaSphere. 7 (2023) S3 - p. e6855326 , 2023

Link: https://doi.org/10.1097/..

12

P647: RACIAL DISPARITIES IN REAL-WORLD TREATMENT PATTERNS A..:

Rhodes, Joanna ; Shadman, Mazyar ; Lamanna, Nicole...
HemaSphere. 7 (2023) S3 - p. e96103aa , 2023

Link: https://doi.org/10.1097/..

13

P631: CHARACTERIZATION OF ZANUBRUTINIB SAFETY/TOLERABILITY ..:

Brown, Jennifer R. ; Eichhorst, Barbara ; Ghia, Paolo...
HemaSphere. 7 (2023) S3 - p. e356884b , 2023

Link: https://doi.org/10.1097/..

14

Mycorrhizal feedbacks influence global forest structure and..:

Delavaux, Camille S. ; LaManna, Joseph A. ; Myers, Jonathan A....
Communications Biology. 6 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

15

P640: ZANUBRUTINIB VS IBRUTINIB IN RELAPSED/REFRACTORY CHRO..:

Eichhorst, Barbara ; Lamanna, Nicole ; O'brien, Susan...
HemaSphere. 7 (2023) S3 - p. e02428b9 , 2023

Link: https://doi.org/10.1097/..